Highfield Diagnostics
Highfield Diagnostics, established in 2017 as a spin-out from the University of Southampton, is dedicated to creating innovative point-of-care diagnostic solutions. With over 50 years of combined academic and practical experience, the company specializes in laser-patterned, paper-based diagnostics that are rapid, portable, and capable of diagnosing multiple conditions simultaneously. Their technology, flowDx, enhances lateral flow tests by increasing sensitivity, enabling multiplexing, and providing semi-quantitative results. Highfield Diagnostics collaborates with global partners and academic institutions to develop and commercialize advanced diagnostic devices for various health challenges, including infectious diseases and cancer detection.
Industries
Nr. of Employees
small (1-50)
Highfield Diagnostics
Southampton, England, United Kingdom
Products
Hi-Sens CRP/SAA Rapid Test
A high-sensitivity lateral flow immunoassay for simultaneous detection of C-Reactive Protein (CRP) and Serum Amyloid A (SAA) in whole blood, serum or plasma using a two-site sandwich immunoassay format and labelled antibody conjugates.
flowDx
A laser-based platform-technology for patterning building blocks of lateral flow tests to create customized, flow-controlled devices with improved performance and added functionalities.
Highfield Diagnostics Point-of-Care Diagnostic Platform
An advanced patterned paper substrate enabled by laser technology capable of diagnosing multiple conditions in a single, rapid, portable test.
laser-based platform-technology
Laser-based platform-technology developed by Highfield Diagnostics.
Hi-Sens CRP/SAA Rapid Test
A high-sensitivity lateral flow immunoassay for simultaneous detection of C-Reactive Protein (CRP) and Serum Amyloid A (SAA) in whole blood, serum or plasma using a two-site sandwich immunoassay format and labelled antibody conjugates.
flowDx
A laser-based platform-technology for patterning building blocks of lateral flow tests to create customized, flow-controlled devices with improved performance and added functionalities.
Highfield Diagnostics Point-of-Care Diagnostic Platform
An advanced patterned paper substrate enabled by laser technology capable of diagnosing multiple conditions in a single, rapid, portable test.
laser-based platform-technology
Laser-based platform-technology developed by Highfield Diagnostics.
Services
Collaborative arrangements and MoUs to integrate laser-patterning technology into industrial lateral flow manufacturing, including equipment finalisation and process development for high-volume production.
Design and development of patterned lateral flow prototypes, multiplex assays, and flow-through filter assays; testing with clinical samples in collaboration with academic and hospital partners.
Collaborative arrangements and MoUs to integrate laser-patterning technology into industrial lateral flow manufacturing, including equipment finalisation and process development for high-volume production.
Design and development of patterned lateral flow prototypes, multiplex assays, and flow-through filter assays; testing with clinical samples in collaboration with academic and hospital partners.
Expertise Areas
- Point-of-care diagnostics
- Lateral flow assay development
- Paper-based microfluidics
- Multiplexed diagnostic assays
Key Technologies
- Laser direct-write patterning
- Paper-based microfluidics
- Lateral flow immunoassays (LFA)
- Multiplexed lateral flow channels
News & Updates
Highfield Diagnostics is part of a consortium that received a £1 million grant from Innovate UK to develop a rapid diagnostic kit for early-stage lung cancer, utilizing flowDx multiplexing technology.
The company developed a pioneering TB triage test and collaborated with researchers in India to refine the prototype, aiming to revolutionize TB screening.
Research article authored by the team on laser-patterned sensors for bacterial detection.
Publication on advanced lateral flow devices for inflammatory biomarker detection.
Received CE Mark approval for the high-sensitivity lateral flow assay for CRP and SAA biomarkers, enabling its use across Europe.
Highfield Diagnostics is part of a consortium that received a £1 million grant from Innovate UK to develop a rapid diagnostic kit for early-stage lung cancer, utilizing flowDx multiplexing technology.
The company developed a pioneering TB triage test and collaborated with researchers in India to refine the prototype, aiming to revolutionize TB screening.
Research article authored by the team on laser-patterned sensors for bacterial detection.
Publication on advanced lateral flow devices for inflammatory biomarker detection.
Received CE Mark approval for the high-sensitivity lateral flow assay for CRP and SAA biomarkers, enabling its use across Europe.